Ethic Inc’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-44,727
Closed -$806K 1314
2025
Q1
$806K Buy
44,727
+1,619
+4% +$28.8K 0.02% 647
2024
Q4
$753K Sell
43,108
-8,990
-17% -$122K 0.02% 678
2024
Q3
$746K Sell
52,098
-20
-0% -$229 0.02% 655
2024
Q2
$590K Buy
52,118
+20
+0% +$266 0.01% 720
2024
Q1
$746K Buy
52,098
+1,264
+2% +$17.9K 0.02% 655
2023
Q4
$697K Buy
50,834
+7,695
+18% +$81K 0.02% 643
2023
Q3
$351K Sell
43,139
-2,858
-6% -$23.4K 0.01% 766
2023
Q2
$348K Buy
45,997
+15,767
+52% +$120K 0.01% 747
2023
Q1
$242K Sell
30,230
-2,901
-9% -$29.8K 0.01% 846
2022
Q4
$376K Buy
33,131
+14,182
+75% +$155K 0.02% 660
2022
Q3
$165K Buy
18,949
+2,856
+18% +$29.7K 0.01% 756
2022
Q2
$160K Buy
+16,093
New +$162K 0.01% 726

Ethic Inc's PTVE Position: Q2 2025 in Review

Ethic Inc sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 44,727 shares — an estimated $806K sold.

Ethic Inc first reported a position in PTVE in Q2 2022 and held it in 12 quarters. The position peaked at $806K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

  • Ethic Inc reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
  • Ethic Inc sold 44,727 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $806K.
  • Ethic Inc first reported a position in Pactiv Evergreen Inc. Common stock in Q2 2022 and held it in 12 quarters.
  • Ethic Inc's Pactiv Evergreen Inc. Common stock position peaked at $806K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Ethic Inc's 13F filing for Q2 2025, filed 30 Jul 2025.